Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21967094 | 1.00 | TSHR (0.32) | TSHRTDP1ALDH1A1CNR1CNR2 | |
| SCHEMBL21967115 | 0.91 | ALDH1A1 (0.37) | TSHRTDP1ALDH1A1CNR1CNR2 | |
| SCHEMBL21967083 | 0.91 | ALDH1A1 (0.37) | TSHRTDP1ALDH1A1CNR1CNR2 | |
| SCHEMBL21484051 | 0.84 | — | — | |
| SCHEMBL21967091 | 0.84 | — | — | |
| SCHEMBL21967111 | 0.81 | ALDH1A1 (0.31) | ALDH1A1CNR1CNR2MEN1CYP3A4 | |
| SCHEMBL21967090 | 0.81 | ASAH1 (0.31) | ALDH1A1CNR1CNR2MEN1CYP3A4 | |
| SCHEMBL21967112 | 0.81 | ALDH1A1 (0.31) | ALDH1A1CNR1CNR2MEN1CYP3A4 | |
| SCHEMBL21967095 | 0.81 | ASAH1 (0.31) | ALDH1A1CNR1CNR2MEN1CYP3A4 | |
| SCHEMBL29109095 | 0.81 | ALDH1A1 (0.31) | ALDH1A1CNR1CNR2MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110551009-B | Process for the preparation of (2E, 6Z) -2, 6-nonenal and (2E) -cis-6, 7-epoxy-2-nonenal | 信越化学工业株式会社 | 2023-10-20 | — | — | CN | disclosed |
| US-10662166-B2 | Process for preparing (2E,6Z)-2,6-nonadienal and a process for preparing (2E)-cis 6,7-epoxy-2-nonenal | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-05-26 | — | — | US | disclosed |
| CN-110551009-A | Process for the preparation of (2E,6Z) -2, 6-nonadienal and (2E) -cis-6, 7-epoxy-2-nonenal | SHINETSU CHEMICAL CO | 2019-12-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662166-B2 | Process for preparing (2E,6Z)-2,6-nonadienal and a process for preparing (2E)-cis 6,7-epoxy-2-nonenal | CYP2E1, CYP2A6, CYP2J2 | TSHR 3746/4885TDP1 4261/4885ALDH1A1 46/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.